A Prospective Multi-Centered Registry-Based Observational Study for Patients With Cancer: Design and Rationale for Korean Medicine Cancer Registry (KMCARE)
Open Access
- 4 January 2024
- journal article
- research article
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 23
Abstract
Background: Cancer is one of the leading causes of death in most countries with an expected increased burden on healthcare systems. Since integrative medical treatments are not collected within the scope of existing cancer registries, the establishment of the Korean Medicine Cancer Registry (KMCARE), gathering integrative therapies, including conservative care and Korean medicine, is warranted. Methods: A prospective observational study based on the registry will be conducted in 5 Korean medical hospitals. A total of 650 eligible participants undergoing Korean medicine treatments within 1 month of a diagnosis of lung, colorectal, stomach, or breast cancer are anticipated to be enrolled in the registry. Data collected in the KMCARE can be classified into patient information, received treatments, and outcomes. The primary outcome is the Functional Assessment of Cancer Therapy-General Questionnaire score at 3 months. Secondary outcomes include the MD Anderson Symptom Inventory-Core and the Body Constitution Questionnaire at 3 and 6 months. After 6 months of follow-up periods, survival surveillance will be continued for additional 18 months. Descriptive and statistical analysis of primary and secondary outcomes, baseline data, safety, survival, and prognostic factors will be performed. Discussion: This is the first prospective, multi-centered, registry-based observational study of cancer patients in Korean medicine hospitals, which could reveal the current status of cancer patients receiving integrative cancer therapies, and provide better insight into the role of Korean medicine in palliative care for patients with cancer. Trial registration: Clinical Research Information Service (CRIS), KCT0007447.Keywords
Funding Information
- Korea Health Industry Development Institute (HF20C0038)
This publication has 23 references indexed in Scilit:
- Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based StudyIntegrative Cancer Therapies, 2017
- Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort studyJournal of Ethnopharmacology, 2017
- Characteristics of Traditional Chinese Medicine Use in Pediatric Cancer Patients: A Nationwide, Retrospective, Taiwanese-Registry, Population-Based StudyIntegrative Cancer Therapies, 2016
- Cancer registry data: Engaging the clinician to improve qualityCancer, 2015
- The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and researchAnnals of Oncology, 2012
- An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosisJournal of Ethnopharmacology, 2012
- How Many Cancer Patients Use Complementary and Alternative MedicineIntegrative Cancer Therapies, 2011
- Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008Health and Quality of Life Outcomes, 2009
- The role of the cancer registry in cancer controlCancer Causes & Control, 1992